CoChat

Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review

Open access
Ferrero, Simone, Gillott, David J, Venturini, Pier L, Remorgida, Valentino · 2011 · Reproductive Biology and Endocrinology

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

This systematic review aims to assess the efficacy of aromatase inhibitors (AIs) in treating pain symptoms caused by endometriosis. A comprehensive literature search was conducted to identify all the published studies evaluating the efficacy of type II nonsteroidal aromatase inhibitors (anastrozole and letrozole) in treating endometriosis-related pain symptoms. The MEDLINE, EMBASE, PubMed, and SCOPUS databases and the Cochrane System Reviews were searched up to October 2010. This review comprises of the results of 10 publications fitting the inclusion criteria; these studies included a total of 251 women. Five studies were prospective non-comparative, four were randomized controlled trials (RCTs) and one was a prospective patient preference trial. Seven studies examined the efficacy of AIs in improving endometriosis-related pain symptoms, whilst three RCTs investigated the use of AIs as post-operative therapy in preventing the recurrence of pain symptoms after surgery for endometriosis. All the observational studies demonstrated that AIs combined with either progestogens or oral contraceptive pill reduce the severity of pain symptoms and improve quality of life. One patient preference study demonstrated that letrozole combined with norethisterone acetate is more effective in reducing pain and deep dyspareunia than norethisterone acetate alone. However, letrozole causes a higher incidence of adverse effects and does not improve patients' satisfaction or influence recurrence of symptoms after discontinuation of treatment. A RCT showed that combining letrozole with norethisterone acetate causes a lower incidence of adverse effects and lower discontinuation rate than combining letrozole with triptorelin. Two RCTs demonstrated that, after surgical treatment of endometriosis, the administration of AIs combined with gonadotropin releasing hormone analogue for 6 months reduces the risk of endometriosis recurrence when compared with gonadotropin releasing hormone analogue alone. In conclusion, AIs effectively reduce the severity of endometriosis-related pain symptoms. Since endometriosis is a chronic disease, future investigations should clarify whether the long-term administration of AIs is superior to currently available endocrine therapies in terms of improvement of pain, adverse effects and patient satisfaction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7827-9-89

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study selection flow chart.
Figure 1 Study selection flow chart.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. 10.1210/jc.81.1.174 · DOI · Paper page

Cited by

  • Endometriosis

    Zondervan, K. T., Becker, C. M., & Missmer, S. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810764 · Cited by 2,249

  • ESHRE guideline: management of women with endometriosis

    Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211

    “…endometriosis, refractory to other medical or surgical treatment, clinicians can consider prescribing aromatase inhibitors in combination with oral contraceptive pills, progestagens or GnRH analogues, as they reduce endometriosis-associated pain (Nawathe et al., 2008; Ferrero et al., 2011).”
    Background
  • ESHRE guideline: endometriosis

    Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712

    “Aromatase inhibitors may be prescribed in combination with oral contraceptives, progestogens, GnRH agonists or GnRH antagonists (Ferrero et al. , 2011; Almassinokiani et al. , 2014; Agarwal and Foster, 2015).”
    Self-citation
  • Consensus on current management of endometriosis

    Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558

    “…ic.oup.com /hum rep/article-abstract/28/6/1552/603470 by guest on 16 M arch 2020 (anastrazole, fadrozole, formestane, exemestane, letrozole) (Ferrero et al., 2011), selective progesterone receptor modulator (mifepristone, ulipristal) (Guo et al., 2011) and orally active GnRH antagonists…”
    Background
  • Hormonal treatments for endometriosis: The endocrine background

    Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336

See all 109

Metadata

Authors
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V.
Affiliations
  • Queen Mary University of London (GB)
  • Ospedale Policlinico San Martino (IT)
Corresponding author
Ferrero, Simone
Venue
Reproductive Biology and Endocrinology
Published
2011
Volume
9
Issue
1
Pages
89
ISSN
1477-7827 (ISSN-L)
OpenAlex
W2103212783
Cited by
109
References
56
Citations by year
2026: 7 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 10 · 2018: 6 · 2017: 9 · 2016: 3 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 7
FWCI
1.23
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Reproductive Biology and Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, aromatase inhibitors, anastrozole, letrozole, dyspareunia, endometriosis-associated pain, postoperative recurrence prevention, GnRH analogues, triptorelin, norethisterone acetate, progestogens, oral contraceptives, endocrine therapy, adverse effects, quality of life
MeSH terms
Letrozole, Anastrozole, Clinical Trials as Topic, Endometriosis, Female, Humans, Nitriles, Postoperative Pain, Triazoles, Pelvic Pain, Aromatase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. https://app.cochat.ai/papers/10.1186/1477-7827-9-89
The paper
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V. (2011). Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reproductive Biology and Endocrinology. https://doi.org/10.1186/1477-7827-9-89

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.